Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-097062
Filing Date
2024-09-04
Accepted
2024-09-04 21:53:47
Documents
1
Period of Report
2024-08-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2423415-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2423415-4_4seq1.xml 4 6049
  Complete submission text file 0001104659-24-097062.txt   7617
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Issuer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AEON BIOPHARMA, INC. 5 PARK PLAZA, SUITE 1750 IRVINE CA 92614
Business Address
Sy Jennifer (Reporting) CIK: 0002023998 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40021 | Film No.: 241279724